Commenting on the publication today of the NHS monthly performance statistics, Tim Gardner, Assistant Director of Policy at the Health Foundation, said.
A2 Bio has two ongoing Phase I/II clinical trials investigating two of its CAR-T programmes. Credit: THOMAS COEX via Getty Images. US-based biotech company A2
An FDA advisory committee mostly agreed on Friday that an investigational once-weekly insulin product carries too much risk for adults with type 1 diabetes to
NHS still faces waiting list challenges
Researchers discover a molecular switch that regulates lipid metabolism in cells
Our body’s fat metabolism plays a vital role in energy production in our body. A research team at the University of Basel, Switzerland, has discovered
A2 Biotherapeutics raises $80m to advance CAR-T therapies for solid tumours – Pharmaceutical Technology
A2 Bio has two ongoing Phase I/II clinical trials investigating two of its CAR-T programmes. Credit: THOMAS COEX via Getty Images. US-based biotech company A2
FDA Advisors Not Convinced Once-Weekly Insulin Is Safe in Type 1 Diabetes
An FDA advisory committee mostly agreed on Friday that an investigational once-weekly insulin product carries too much risk for adults with type 1 diabetes to